FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company - Human leukocyte antigen - Document - PDFSEARCH.IO

First Page	Meta Content
	FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company Add to Reading List Document Date: 2016-05-24 10:55:48 Open Document File Size: 35,64 KB Share Result on Facebook

FOR IMMEDIATE RELEASE ImmusanT Reports Nexvax2 Phase 1 Data in Patients with Celiac Disease - Data Presented at Digestive Disease Week 2016 CAMBRIDGE, Mass. – May 24, 2016 – ImmusanT, Inc., a clinical-stage company Add to Reading List